$23.95 -0.16 (-0.66%)
11/27/2009 1:00 PM

Myriad Genetics, Inc. (MYGN)

CAPS Rating: 4 out of 5

Myriad Genetics is focused on developing and marketing novel molecular diagnostic products.

Featured Broker Partners